 |
|
|||||||||||||||||||||||||||||||||
| [發表評論] [本類其他產品] [本類其他供應商] [收藏] | ||||||||||||||||||||||||||||||||||
| 銷售商： 杭州華安生物技術有限公司 | 查看該公司所有產品 >> |
Fig1: Western blot analysis of EIF2A on human EIF2A recombinant protein using anti-EIF2A antibody at 1/1,000 dilution.
Fig2: Western blot analysis of EIF2A on HEK293 (1) and EIF2A-hIgGFc transfected HEK293 (2) cell lysate using anti-EIF2A antibody at 1/1,000 dilution.
Fig3: Western blot analysis of EIF2A on different cell lysate using anti-EIF2A antibody at 1/1,000 dilution. Positive control： Line1: MCF-7 Line2: PC-12 Line3: HepG2 Line4: Hela Line5: Cos7 Line6: K562 Line7: Jurkat Line8: A431 Line9:
Fig4: ICC staining EIF2A (green) in HepG2 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Fig5: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti-EIF2A antibody. Counter stained with hematoxylin.
Fig6: Flow cytometric analysis of HepG2 cells with EIF2A antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).
如有售后問題可及時聯系我們，我們會有售后人員為您解決問題，聯系電話0571-89986345。
手機版：EIF2A 鼠單克隆抗體
Copyright(C) 1998-2025 生物器材網 電話：021-64166852;13621656896 E-mail：info@bio-equip.com